Clinical Trials Insight: 700022740
Latest Information Update: 26 Apr 2007
Price :
$35 *
At a glance
- Drugs Azacitidine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- Sponsors Pharmion Corporation
- 26 Apr 2007 New trial record.